Bowman-Birk Inhibitor Concentrate in Healthy Men

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy, no Evidence of Disease

In brief

This randomized phase I trial is studying the side effects and best dose of Bowman-Birk inhibitor concentrate in healthy men. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of Bowman-Birk inhibitor concentrate may prevent cancer.

Key facts

Study ID
NCT00679094
Run by
National Cancer Institute (NCI)
People needed
20
Starts
2007-06-01
Expected to finish
2009-12-01
Last updated by the study team
2016-12-29

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.